Sangamo Biosciences reported $0 in Debt for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Alnylam Pharmaceuticals ALNY:US $ 676.71M 1.01M
Amgen AMGN:US $ 36854M 3545M
Avrobio Inc AVRO:US $ 15.02M 75K
Bayer BAYN:GR € 42547M 1675M
Biocryst Pharmaceuticals BCRX:US $ 604.46M 19M
Biogen BIIB:US $ 7275.2M 2.1M
Biomarin Pharmaceutical BMRN:US $ 1080.06M 0.98M
Bluebird Bio BLUE:US $ 0M 0M
Gilead Sciences GILD:US $ 26208M 487M
GlaxoSmithKline GSK:LN 33328M 9155M
Intercept Pharmaceuticals ICPT:US $ 716.88M 177.1M
IONIS PHARMACEUT IONS:US $ 1252.14M 23.19M
Johnson & Johnson JNJ:US $ 33148M 603M
Karyopharm Therapeutics KPTI:US $ 302.49M 198K
Merk MRK:US $ 31794M 1308M
Novartis NOVN:VX SF 31275M 250M
Omeros OMER:US $ 313.9M 517K
Pfizer PFE:US $ 36301M 2135M
Regulus Therapeutics RGLS:US $ 4.41M 0.26M
Sangamo Biosciences SGMO:US $ 0M 0M
Sarepta Therapeutics SRPT:US $ 1098.85M 1.97M
Ultragenyx Pharmaceutical RARE:US $ 0M 0.98M
Vertex Pharmaceuticals VRTX:US $ 495.5M 14.3M
Ziopharm Oncology ZIOP:US $ 24.32M 0.2M